Advertisement
Screener

Savara Inc (SVRA) Earnings Per Share, Basic and Diluted

2.8 / 5 stars · 68/120 Roast Me

Savara Inc Earnings Per Share, Basic and Diluted

Savara Inc (SVRA) reported Earnings Per Share, Basic and Diluted of -$0.05 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-11.

Discontinued › Income Statement › Earnings Per Share

us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-11

  • Savara Inc earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.05.
  • Savara Inc earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.07.
  • Savara Inc earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.07.
  • Savara Inc earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.07.
  • Savara Inc earnings per share, basic and diluted for fiscal 2021 was -$0.32.
  • Savara Inc earnings per share, basic and diluted for fiscal 2020 was -$0.84.
  • Savara Inc earnings per share, basic and diluted for fiscal 2019 was -$1.95.
  • Savara Inc earnings per share, basic and diluted for fiscal 2018 was -$1.85.
Period endEarnings Per Share, Basic and Diluted 3 monthEarnings Per Share, Basic and Diluted 3 month as first filedEarnings Per Share, Basic and Diluted 6 monthEarnings Per Share, Basic and Diluted 6 month as first filedEarnings Per Share, Basic and Diluted 9 monthEarnings Per Share, Basic and Diluted 9 month as first filedEarnings Per Share, Basic and Diluted 12 monthEarnings Per Share, Basic and Diluted 12 month as first filed
2022-03-31-$0.05
10-Q · filed 2022-05-11
-$0.13
derived: net income ÷ weighted average shares · filed 2023-05-15
-$0.20
derived: net income ÷ weighted average shares · filed 2023-05-15
-$0.27
derived: net income ÷ weighted average shares · filed 2023-05-15
2021-12-31-$0.07
derived: net income ÷ weighted average shares · filed 2023-03-30
-$0.14
derived: net income ÷ weighted average shares · filed 2023-03-30
-$0.21
derived: net income ÷ weighted average shares · filed 2023-03-30
-$0.32
10-K · filed 2022-03-30
2021-09-30-$0.07
10-Q · filed 2021-11-12
-$0.14
derived: net income ÷ weighted average shares · filed 2022-11-10
-$0.25
10-Q · filed 2021-11-12
-$0.41
derived: net income ÷ weighted average shares · filed 2022-11-10
2021-06-30-$0.07
10-Q · filed 2021-08-12
-$0.18
10-Q · filed 2021-08-12
-$0.36
derived: net income ÷ weighted average shares · filed 2022-08-11
-$0.52
derived: net income ÷ weighted average shares · filed 2022-08-11
2021-03-31-$0.13
10-Q · filed 2022-05-11
-$0.35
derived: net income ÷ weighted average shares · filed 2022-05-11
-$0.53
derived: net income ÷ weighted average shares · filed 2022-05-11
-$0.69
derived: net income ÷ weighted average shares · filed 2022-05-11
2020-12-31-$0.23
derived: net income ÷ weighted average shares · filed 2022-03-30
-$0.41
derived: net income ÷ weighted average shares · filed 2022-03-30
-$0.57
derived: net income ÷ weighted average shares · filed 2022-03-30
-$0.84
10-K · filed 2022-03-30
2020-09-30-$0.18
10-Q · filed 2021-11-12
-$0.34
derived: net income ÷ weighted average shares · filed 2021-11-12
-$0.61
10-Q · filed 2021-11-12
-$1.23
derived: net income ÷ weighted average shares · filed 2021-11-12
2020-06-30-$0.16
10-Q · filed 2021-08-12
-$0.43
10-Q · filed 2021-08-12
-$1.06
derived: net income ÷ weighted average shares · filed 2021-08-12
-$1.37
derived: net income ÷ weighted average shares · filed 2021-08-12
2020-03-31-$0.27
10-Q · filed 2021-05-13
-$0.93
derived: net income ÷ weighted average shares · filed 2021-05-13
-$1.25
derived: net income ÷ weighted average shares · filed 2021-05-13
-$1.80
derived: net income ÷ weighted average shares · filed 2021-05-13
2019-12-31-$0.72
10-K · filed 2020-03-12
-$1.03
derived: net income ÷ weighted average shares · filed 2021-03-10
-$1.60
derived: net income ÷ weighted average shares · filed 2021-03-10
-$1.95
10-K · filed 2021-03-10
2019-09-30-$0.30
10-Q · filed 2020-11-05
-$0.86
derived: net income ÷ weighted average shares · filed 2020-11-05
-$1.20
10-Q · filed 2020-11-05
-$1.50
derived: net income ÷ weighted average shares · filed 2020-11-05
2019-06-30-$0.57
10-Q · filed 2020-08-06
-$0.91
10-Q · filed 2020-08-06
-$1.21
derived: net income ÷ weighted average shares · filed 2020-08-06
-$1.58
derived: net income ÷ weighted average shares · filed 2020-08-06
2019-03-31-$0.34
10-Q · filed 2020-05-07
-$0.63
derived: net income ÷ weighted average shares · filed 2020-05-07
-$0.99
derived: net income ÷ weighted average shares · filed 2020-05-07
-$1.36
derived: net income ÷ weighted average shares · filed 2020-05-07
2018-12-31-$0.29
10-K · filed 2020-03-12
-$0.66
derived: net income ÷ weighted average shares · filed 2020-03-12
-$1.02
derived: net income ÷ weighted average shares · filed 2020-03-12
-$1.85
10-K · filed 2020-03-12
2018-09-30-$0.36
10-K · filed 2020-03-12
-$0.37
10-Q · filed 2018-11-07
-$0.73
derived: net income ÷ weighted average shares · filed 2019-11-07
-$1.57
10-Q · filed 2019-11-07
-$1.61
10-Q · filed 2018-11-07
-$1.83
derived: net income ÷ weighted average shares · filed 2019-11-07
2018-06-30-$0.37
10-K · filed 2020-03-12
-$0.38
10-Q · filed 2018-08-09
-$1.23
10-Q · filed 2019-08-08
-$1.26
10-Q · filed 2018-08-09
-$1.47
derived: net income ÷ weighted average shares · filed 2019-08-08
-$1.79
derived: net income ÷ weighted average shares · filed 2019-08-08
2018-03-31-$0.86
10-K · filed 2020-03-12
-$0.88
10-Q · filed 2018-05-09
-$1.11
derived: net income ÷ weighted average shares · filed 2019-05-09
-$1.43
derived: net income ÷ weighted average shares · filed 2019-05-09
-$2.15
derived: net income ÷ weighted average shares · filed 2019-05-09
2017-12-31-$0.23
10-K · filed 2019-03-13
-$0.50
derived: net income ÷ weighted average shares · filed 2019-03-13
-$1.16
derived: net income ÷ weighted average shares · filed 2019-03-13
-$1.76
10-K · filed 2019-03-13
2017-09-30-$0.28
10-K · filed 2019-03-13
-$1.01
derived: net income ÷ weighted average shares · filed 2018-11-07
-$1.76
10-Q · filed 2018-11-07
-$0.43
derived: net income ÷ weighted average shares · filed 2018-11-07
2017-06-30-$0.90
10-K · filed 2019-03-13
-$2.06
10-Q · filed 2018-08-09
-$0.27
derived: net income ÷ weighted average shares · filed 2018-08-09
-$0.41
derived: net income ÷ weighted average shares · filed 2018-08-09
2017-03-31-$0.97
10-K · filed 2019-03-13
-$1.61
10-Q · filed 2017-05-09
-$0.09
derived: net income ÷ weighted average shares · filed 2018-05-09
-$0.17
derived: net income ÷ weighted average shares · filed 2018-05-09
-$0.26
derived: net income ÷ weighted average shares · filed 2018-05-09
2016-12-31-$1.31
10-K · filed 2018-03-14
-$0.02
10-K · filed 2017-03-06
-$0.08
derived: net income ÷ weighted average shares · filed 2017-11-08
-$0.14
derived: net income ÷ weighted average shares · filed 2017-11-08
-$5.62
10-K · filed 2018-03-14
-$0.17
10-K · filed 2017-03-06
2016-09-30-$1.21
10-K · filed 2018-03-14
-$0.04
10-Q · filed 2016-11-08
-$2.84
derived: net income ÷ weighted average shares · filed 2017-11-08
-$4.40
10-Q · filed 2017-11-08
-$0.15
10-Q · filed 2016-11-08
-$0.63
derived: net income ÷ weighted average shares · filed 2017-11-08
2016-06-30-$1.97
10-K · filed 2018-03-14
-$0.05
10-Q · filed 2016-08-09
-$3.63
10-Q · filed 2017-08-09
-$0.12
10-Q · filed 2016-08-09
-$0.42
derived: net income ÷ weighted average shares · filed 2017-08-09
-$0.40
derived: net income ÷ weighted average shares · filed 2017-08-09
2016-03-31-$0.97
10-K · filed 2018-03-14
-$0.06
10-Q · filed 2016-05-06
-$0.26
derived: net income ÷ weighted average shares · filed 2017-05-09
-$0.28
derived: net income ÷ weighted average shares · filed 2017-05-09
-$0.34
derived: net income ÷ weighted average shares · filed 2017-05-09
2015-12-31-$0.06
10-K · filed 2017-03-06
-$0.12
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.19
derived: net income ÷ weighted average shares · filed 2017-03-06
-$9.48
10-K · filed 2018-03-14
-$0.25
10-K · filed 2016-03-14
2015-09-30-$0.06
10-K · filed 2017-03-06
-$0.12
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.18
10-Q · filed 2016-11-08
-$0.23
derived: net income ÷ weighted average shares · filed 2017-03-06
2015-06-30-$0.06
10-K · filed 2017-03-06
-$0.12
10-Q · filed 2016-08-09
-$0.17
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.24
derived: net income ÷ weighted average shares · filed 2017-03-06
2015-03-31-$0.06
10-K · filed 2017-03-06
-$0.11
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.17
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.24
derived: net income ÷ weighted average shares · filed 2017-03-06
2014-12-31-$0.05
10-K · filed 2017-03-06
-$0.11
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.17
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.23
10-K · filed 2017-03-06
2014-09-30-$0.06
10-K · filed 2017-03-06
-$0.13
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.19
10-Q · filed 2015-11-12
-$0.24
derived: net income ÷ weighted average shares · filed 2017-03-06
2014-06-30-$0.06
10-K · filed 2017-03-06
-$0.12
10-Q · filed 2015-08-12
-$0.18
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.23
derived: net income ÷ weighted average shares · filed 2017-03-06
2014-03-31-$0.06
10-K · filed 2017-03-06
-$0.12
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.17
derived: net income ÷ weighted average shares · filed 2017-03-06
-$0.24
derived: net income ÷ weighted average shares · filed 2017-03-06
2013-12-31-$0.06
10-K · filed 2015-03-24
-$0.11
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.18
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.28
10-K · filed 2015-03-24
2013-09-30-$0.05
10-K · filed 2015-03-24
-$0.13
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.23
10-Q · filed 2014-10-31
-$0.32
derived: net income ÷ weighted average shares · filed 2015-03-24
2013-06-30-$0.09
10-K · filed 2015-03-24
-$0.21
10-Q · filed 2014-08-11
-$0.30
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.36
derived: net income ÷ weighted average shares · filed 2015-03-24
2013-03-31-$0.12
10-K · filed 2015-03-24
-$0.20
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.27
derived: net income ÷ weighted average shares · filed 2015-03-24
-$0.36
derived: net income ÷ weighted average shares · filed 2015-03-24
2012-12-31-$0.08
10-K · filed 2014-03-26
-$0.15
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.24
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.33
10-K · filed 2014-03-26
2012-09-30-$0.07
10-K · filed 2014-03-26
-$0.16
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.24
10-Q · filed 2013-11-04
-$0.31
derived: net income ÷ weighted average shares · filed 2014-03-26
2012-06-30-$0.09
10-K · filed 2014-03-26
-$0.18
10-Q · filed 2013-08-05
-$0.24
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.36
derived: net income ÷ weighted average shares · filed 2014-03-26
2012-03-31-$0.09
10-K · filed 2014-03-26
-$0.15
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.27
derived: net income ÷ weighted average shares · filed 2014-03-26
-$0.42
derived: net income ÷ weighted average shares · filed 2014-03-26
2011-12-31-$0.06
10-K · filed 2013-03-19
-$0.19
derived: net income ÷ weighted average shares · filed 2013-03-19
-$0.34
derived: net income ÷ weighted average shares · filed 2013-03-19
-$0.47
10-K · filed 2013-03-19
2011-09-30-$0.13
10-K · filed 2013-03-19
-$0.30
derived: net income ÷ weighted average shares · filed 2013-03-19
-$0.43
10-Q · filed 2012-11-05
2011-06-30-$0.17
10-K · filed 2013-03-19
-$0.30
10-Q · filed 2012-08-06
2011-03-31-$0.13
10-K · filed 2013-03-19
2010-12-31-$1.07
10-K · filed 2012-03-08
2010-09-30-$0.13
10-Q · filed 2011-11-08
-$0.94
10-Q · filed 2011-11-08
2010-06-30-$0.39
10-Q · filed 2011-08-08
-$0.86
10-Q · filed 2011-08-08

Similar stocks

Stock NameCountryMarket CapPE Ratio
MoonLake Immunotherapeutics (MLTX)Switzerland$1.031B-5.43
MANNKIND CORP (MNKD)United States$1.058B-30.41
Alto Neuroscience, Inc. (ANRO)United States$1.065B-11.02
Pacira BioSciences, Inc. (PCRX)United States$1.020B69.03
Janux Therapeutics, Inc. (JANX)United States$1.019B-9.15
Corvus Pharmaceuticals, Inc. (CRVS)United States$0.994B-23.25
Amphastar Pharmaceuticals, Inc. (AMPH)United States$1.116B10.93
Kura Oncology, Inc. (KURA)United States$0.967B-3.29
Arbutus Biopharma Corp (ABUS)$0.965B6.19
Seaport Therapeutics, Inc. (SPTX)United States$1.131B